Count on us for updates on the coronavirus and guidance for cancer patients and family members.Read the latest articles
Peter Hillmen is a Consultant Hematologist at the Leeds Teaching Hospitals NHS Trust and is based at St. James University Hospital in Leeds, UK. He obtained his medical degree from Leeds Medical School in 1985, followed by general medical training in Leeds. He then spent two ears at Hammersmith Hospital training in hematology followed by three years researching under the supervision of Professor Lucio Luzzatto at the Royal Postgraduate Medical School. He was awarded a PhD by the University of London for research into paroxysmal nocturnal hemoglobinuria (PNH), before completing his training in hematology in Leeds. His clinical and research interests include chronic lymphocytic leukemia (CLL) and PNH. He is Chairman of the CLL trials subgroup of the National Cancer Research Institute (NCRI), with the responsibility of developing a portfolio of phase II and III studies in CLL for the UK. Dr. Hillmen is also the Chairman of the International PNH Interest Group. He is principal investigator of several national and international phase II and III trials for CLL and PNH.